✦ LIBER ✦

ChemInform Abstract: KNI-272, a Highly Selective and Potent Peptidic HIV Protease Inhibitor

✍ Scribed by Mitsunobu Doi; Toshimasa Ishida; Yoshio Katsuya; Masahiro Sasaki; Taizo Taniguchi; Hiroshi Hasegawa; Tsutomu Mimoto; Yoshiaki Kiso

Publisher: John Wiley and Sons
Year: 2010
Weight: 29 KB
Volume: 33
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200209193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Physiologically based pharmacokinetics o

Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor

✍ Akiko Kiriyama; Tomoyuki Nishiura; Hirokazu Yamaji; Kanji Takada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The effects of dose on the pharmacokinetic characteristics of KNI-272 were evaluated in rats after intravenous (iv) administration. The plasma kinetics of KNI-272 were dose-independent within a dose range of 1.0 to 10.0 mg/kg. However, when the dose was increased to 50.0 mg/kg, the area under the pl

Targets of a protease inhibitor, KNI-272

Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells

✍ Toshiyuki Goto; Takashi Nakano; Takehiro Kohno; Shinichi Morimatsu; Chizuko Mori 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Conformational analysis of HIV-1 proteas

Conformational analysis of HIV-1 protease inhibitors: 2. Thioproline P1? Residue in the potent inhibitor KNI-272

✍ Murcko, Mark A.; Rao, B. Govinda; Gomperts, Roberto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

does not contain a basic amine as do Saquinovir and JG-365, for example it should be easier to desolvate, which also assists in binding. The relationship between KNI-272, JG-365, Saquinovir, and P X proline-containing substrate also is 1

ChemInform Abstract: Practical, Stereose

ChemInform Abstract: Practical, Stereoselective Synthesis of Palinavir, a Potent HIV Protease Inhibitor.

✍ P. L. BEAULIEU; P. LAVALLEE; A. ABRAHAM; P. C. ANDERSON; C. BOUCHER; Y. BOUSQUET 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Absorption of new HIV-1 protease inhibit

Absorption of new HIV-1 protease inhibitor, KNI-272, after intraduodenal and intragastric administrations to rats: Effect of solvent

✍ M. Sugahara; A. Kiriyama; Y. Hamada; Y. Kiso; K. Takada 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 2 views

KNI-272 is a tripeptide drug that has a strong pharmacological potential for treating human immunodeficiency virus type 1 (HIV-1). We have already reported the pharmacokinetic characteristics of KNI-272 after intravenous and intraduodenal (ID) administrations to rats. In this study, KNI-272 was admi

ChemInform Abstract: A Concise Formal Sy

ChemInform Abstract: A Concise Formal Synthesis of the Potent HIV Protease Inhibitor Nelfinavir Mesylate.

✍ D. L. RIEGER 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views